Showing results (381-390 of 461) with videos related to

Sort By:
Pageof 47
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|September 1, 1989
[Survivals of incidental renal cell carcinoma]T Igarashi, S Murakami, S Tomioka, et al.
American Journal of Ophthalmology|July 1, 1996
Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndromeK Tsubota, Y Satake, M Ohyama, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 15, 2001
Hepatoid adenocarcinoma of the stomachS Inagawa, J Shimazaki, M Hori, et al.
Japanese Journal of Cancer Research : Gann|October 1, 1995
Microsatellite instability and other molecular abnormalities in human prostate cancerH Suzuki, A Komiya, S Aida, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|August 1, 1994
[The role of repeat transurethral resection in stage A1 carcinoma of the prostate]S Murakami, T Igarashi, T Yuhiki, et al.
Surgery Today|January 1, 1993
Combined treatment of pelvic exenterative surgery and intra-operative pelvic hyperthermochemotherapy for locally advanced rectosigmoid cancer: report of a caseS Fujimoto, M Takahashi, K Kobayashi, et al.
Biochemical and Biophysical Research Communications|March 18, 1999
Human MD-1 homologue is a BCG-regulated gene product in monocytes: its identification by differential displayN A Begum, S Tsuji, M Nomura, et al.
International Archives of Allergy and Immunology|May 5, 1998
Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte culturesK Shida, K Makino, A Morishita, et al.
Beneficial Microbes|December 22, 2017
Effects of fermented soymilk with Lactobacillus casei Shirota on skin condition and the gut microbiota: a randomised clinical pilot trialT Nagino, C Kaga, M Kano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1983
[Combination of intra-arterial administration of anticancer agent and hemocarboperfusion in treatment of advanced cancer]J Yamagata, T Agishi, K Ota, et al.
Pageof 47